Tesamorelin

Description

Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), engineered with a trans-2-hexenoic acid modification that significantly enhances plasma stability relative to native GHRH. This structural modification makes it a preferred research tool in studies examining growth hormone secretion dynamics, IGF-1 signaling cascades, and pituitary axis regulation. Its well-characterized pharmacokinetic profile supports reproducible, data-consistent experimental designs.

Tesamorelin has one of the more robust human clinical research profiles of any synthetic GHRH analogue, with published trials examining visceral adiposity reduction, body composition in HIV-associated lipodystrophy, and cognitive function in older adults with mild cognitive impairment. Research has also investigated its effects on GH pulse amplitude, IGF-1 normalization, and lipid metabolism, providing a substantial data foundation for ongoing endocrine and metabolic studies.

Each vial contains 20mg of lyophilized Tesamorelin at ≥99% purity, produced in a GMP-compliant facility and independently verified by third-party analysis. Full batch COA available. Ships same day from Scottsdale, AZ.

Product Details

• Compound: Tesamorelin (GHRH Analogue)
• Form: Lyophilized powder
• Quantity: 10mg | 20mg per vial
• Purity: ≥99% (third-party verified)
• Storage: Cool, dry environment per standard laboratory protocols